These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16323834)

  • 1. Synthesis and evaluation of sphinganine analogues of KRN7000 and OCH.
    Ndonye RM; Izmirian DP; Dunn MF; Yu KO; Porcelli SA; Khurana A; Kronenberg M; Richardson SK; Howell AR
    J Org Chem; 2005 Dec; 70(25):10260-70. PubMed ID: 16323834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total enantioselective synthesis and in vivo biological evaluation of a novel fluorescent BODIPY alpha-galactosylceramide.
    Vo-Hoang Y; Micouin L; Ronet C; Gachelin G; Bonin M
    Chembiochem; 2003 Jan; 4(1):27-33. PubMed ID: 12512073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syntheses of biotinylated alpha-galactosylceramides and their effects on the immune system and CD1 molecules.
    Sakai T; Naidenko OV; Iijima H; Kronenberg M; Koezuka Y
    J Med Chem; 1999 May; 42(10):1836-41. PubMed ID: 10346936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of hydroxylated analogues of KRN7000 (α-galactosylceramide).
    Shiozaki M; Tashiro T; Koshino H; Shigeura T; Watarai H; Taniguchi M; Mori K
    Carbohydr Res; 2013 Apr; 370():46-66. PubMed ID: 23454137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of 1,2,3-triazole containing analogues of the immunostimulant alpha-GalCer.
    Lee T; Cho M; Ko SY; Youn HJ; Baek DJ; Cho WJ; Kang CY; Kim S
    J Med Chem; 2007 Feb; 50(3):585-9. PubMed ID: 17266209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focus on the controversial activation of human iNKT cells by 4-deoxy analogue of KRN7000.
    Lacône V; Hunault J; Pipelier M; Blot V; Lecourt T; Rocher J; Turcot-Dubois AL; Marionneau S; Douillard JY; Clément M; Le Pendu J; Bonneville M; Micouin L; Dubreuil D
    J Med Chem; 2009 Aug; 52(15):4960-3. PubMed ID: 19580320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of alpha-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3).
    Xia C; Yao Q; Schümann J; Rossy E; Chen W; Zhu L; Zhang W; De Libero G; Wang PG
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2195-9. PubMed ID: 16458002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing effects of (2S,3S,4R)-1-O-(alpha-D-galactopyranosyl)-2-(N-hexacosanoylamino) -1,3,4-octadecanetriol (KRN7000) on antigen-presenting function of antigen-presenting cells and antimetastatic activity of KRN7000-pretreated antigen-presenting cells.
    Yamaguchi Y; Motoki K; Ueno H; Maeda K; Kobayashi E; Inoue H; Fukushima H; Koezuka Y
    Oncol Res; 1996; 8(10-11):399-407. PubMed ID: 9114432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of alpha-galactosyl ceramide (KRN7000) and analogues thereof via a common precursor and their preliminary biological assessment.
    Michieletti M; Bracci A; Compostella F; De Libero G; Mori L; Fallarini S; Lombardi G; Panza L
    J Org Chem; 2008 Nov; 73(22):9192-5. PubMed ID: 18956839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lipid chain lengths in alpha-galactosylceramides on cytokine release by natural killer T cells.
    Goff RD; Gao Y; Mattner J; Zhou D; Yin N; Cantu C; Teyton L; Bendelac A; Savage PB
    J Am Chem Soc; 2004 Oct; 126(42):13602-3. PubMed ID: 15493902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synthesis and in vivo evaluation of 2',2'-difluoro KRN7000.
    Leung L; Tomassi C; Van Beneden K; Decruy T; Trappeniers M; Elewaut D; Gao Y; Elliott T; Al-Shamkhani A; Ottensmeier C; Werner JM; Williams A; Van Calenbergh S; Linclau B
    ChemMedChem; 2009 Mar; 4(3):329-34. PubMed ID: 19137519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activity of ester and ether analogues of alpha-galactosylceramide (KRN7000).
    Shiozaki M; Tashiro T; Koshino H; Nakagawa R; Inoue S; Shigeura T; Watarai H; Taniguchi M; Mori K
    Carbohydr Res; 2010 Aug; 345(12):1663-84. PubMed ID: 20591421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro evaluation of alpha-GalCer epimers.
    Trappeniers M; Goormans S; Van Beneden K; Decruy T; Linclau B; Al-Shamkhani A; Elliott T; Ottensmeier C; Werner JM; Elewaut D; Van Calenbergh S
    ChemMedChem; 2008 Jul; 3(7):1061-70. PubMed ID: 18418814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with EL-4 hepatic metastasis and its cytokine production.
    Nakagawa R; Motoki K; Nakamura H; Ueno H; Iijima R; Yamauchi A; Tsuyuki S; Inamoto T; Koezuka Y
    Oncol Res; 1998; 10(11-12):561-8. PubMed ID: 10367937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of truncated α-galactosylceramide derivatives focusing on cytokine induction profile.
    Toba T; Murata K; Futamura J; Nakanishi K; Takahashi B; Takemoto N; Tomino M; Nakatsuka T; Imajo S; Goto M; Yamamura T; Miyake S; Annoura H
    Bioorg Med Chem; 2012 May; 20(9):2850-9. PubMed ID: 22480852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RCAI-17, 22, 24-26, 29, 31, 34-36, 38-40, and 88, the analogs of KRN7000 with a sulfonamide linkage: their synthesis and bioactivity for mouse natural killer T cells to produce Th2-biased cytokines.
    Tashiro T; Hongo N; Nakagawa R; Seino K; Watarai H; Ishii Y; Taniguchi M; Mori K
    Bioorg Med Chem; 2008 Oct; 16(19):8896-906. PubMed ID: 18790646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pivotal advance: alpha-galactosylceramide induces protection against lipopolysaccharide-induced shock.
    Sireci G; La Manna MP; Di Sano C; Di Liberto D; Porcelli SA; Kronenberg M; Dieli F; Salerno A
    J Leukoc Biol; 2007 Mar; 81(3):607-22. PubMed ID: 17046969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
    Tulley JM; Palmer JL; Gamelli RL; Faunce DE
    Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.
    Yanagisawa K; Exley MA; Jiang X; Ohkochi N; Taniguchi M; Seino K
    Cancer Res; 2006 Dec; 66(23):11441-6. PubMed ID: 17145891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody-induced arthritis.
    Kaieda S; Tomi C; Oki S; Yamamura T; Miyake S
    Arthritis Rheum; 2007 Jun; 56(6):1836-45. PubMed ID: 17530712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.